Transposagen announces partnering model for its exclusive

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Transposagen announces partnering model for its exclusive patents covering rat models of oncology, autoimmune and inflammatory diseases and issuance of OncoRat(TM) registered trademark

Lexington, KY, Apr. 20, 2015 (GLOBE NEWSWIRE) -- Transposagen, a world leader in genome engineering technologies and services, announced the registration of its trademark OncoRat™ by the USPTO, for use with rat models for oncology in issued patent No. 8,722,964. OncoRat™ covers all genetically engineered rat models with oncology phenotypes, regardless of the method used to create the rat model (e.g. site-specific nucleases, homologous recombination, transposon insertion, etc.). 

Access to the creation and use of patented genetically engineered rat lines is being offered solely through comprehensive genome engineering IP licensing and service partnership agreements. Companies that partner with Transposagen will also gain access to genome engineering intellectual property including piggyBac™, NextGEN™ CRISPR and XTN™ TALEN technologies. Transposagen will also perform services for its partners, including custom genetically engineered cell lines, animal models as well as gene editing reagent kits. For more on how it works please visit our  Partnering  page. 

Another issued patent, No. 8,558,055, covers all genetically engineered rat models with autoimmune or inflammatory diseases. Additional pending patents include rats with severe combined immune deficiency (SCID), diabetes, obesity, susceptibility to pain, and phenotypes that are the result of mutations in drug transporter or drug metabolism genes. The phenotype patents also cover cells derived from genetically engineered rat models with specific phenotypes, screening methods, as well as assays and kits for drug discovery purposes.    

Transposagen is the only company that has freedom to operate with both the enabling genome engineering technologies and the rat phenotype patents. Please  contact us  to discuss your custom partnership for access to full freedom to operate and genome engineering services.  

 

Jack Crawford M.Sc. Director, Sales & Marketing Transposagen Biopharmaceuticals 535 West Second St., Suite 10 Lexington, KY 40508 www.transposagenbio.com jcrawford@transposagenbio.com Cell: 315-351-9115

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sussex County Data Breach Raises Security Concerns

Updated Category News Views 142

The Digital Fiasco: A Wake-Up Call Straight out of Sussex County in good ol' New Jersey, we’re staring down another data breach, folks. When you hear about a data privacy incident, there's always that same sinking feeling of another layer of personal security peeled away. This time, the Sussex County Prosecutor's Office got caught in the crossfire, with personal info...

Continue Reading
Key Players Depart No Makeup Makeup Amid Rapid Success

Updated Category News Views 226

Change is afoot in the world of beauty. No Makeup Makeup, a brand that's managed to carve out a sizable niche, recently bid farewell to two of its main architects: Kim Wileman and Shauna Lahiri. These women didn't just steer the ship; they built the damn thing. Kicking Off the No Makeup Revolution Wileman and Lahiri were the pistons firing away at No Makeup Makeup, a...

Continue Reading
Evaluating GLP-1 Telehealth? Key Questions to Consider

Updated Category News Views 166

Navigating the Landscape of GLP-1 Telehealth Providers In the sprawling jungle of telehealth options for GLP-1 care, it's easy to feel like you're drowning in sameness. Picture this: you land on a sleek page promising the moon and stars, but who knows what's behind the curtain? That's where seasoned advice comes in, like a compass in this murky digital forest. Meant, a...

Continue Reading
Sensitron's 270VDC SSPCs: A Power System Shake-Up

Updated Category News Views 208

Revolutionizing Power Distribution with Sensitron Some days, the tech world dishes out real game-changers, and looks like November 6, 2026, was one of those days. Sensitron Semiconductor dropped a bombshell with their SPHM/SEHM Series—a brand-new lineup of programmable 16-channel Solid State Power Controllers (SSPCs). Tailored for the grueling demands of 270VDC power...

Continue Reading
JOYEE N01 Kicks Off Global Launch with African Orders

Updated Category News Views 129

A New Chapter for JOYEE N01 There's a moment in every company's life when it either steps boldly into the future or stumbles back into obscurity. For FAW Bestune, October 28, 2026, was one of those defining moments. On this day, they launched global mass production of the JOYEE N01 in Yancheng, China. And boy, did they pull out all the stops—you don't see this kind of...

Continue Reading
Historic Records Set at 2026 CNO Monumental Marathon

Updated Category News Views 100

Race to Remember: Monumental Breakthroughs In the chilly November air of Indianapolis, the 2026 CNO Financial Indianapolis Monumental Marathon wasn't just another tick on the calendar—this was a banner day for running. With record-breaking performances across every distance, we saw what happens when a community of athletes, sponsors, and volunteers hits a perfect...

Continue Reading
Invasive Procedures Don't Extend Life in Stable Heart Disease

Updated Category News Views 168

Challenging Longstanding Beliefs Today’s news from the heart research front might set a few cardiology heads spinning. We’ve got big-time findings out of the ISCHEMIA-EXTEND study, throwing more weight on the evidence pile that early invasive heart procedures for patients with stable coronary artery disease don’t actually extend your life. Managing care with a blend...

Continue Reading
Pinterest Faces Legal Probe: Investor Concerns Rise

Updated Category News Views 95

Legal Storms Gather on Pinterest's Horizon I remember a time when Pinterest was the darling of Wall Street, but here we are, staring at an investigation that's got more layers than an onion. On November 6, 2026, news broke that Kahn Swick & Foti, LLC (KSF) is sniffing around Pinterest's officers and directors. This is no small fry since KSF is steered by none other than...

Continue Reading
Boston STEM Expo Sparks Young Minds in Engineering

Updated Category News Views 62

If you really want to light up a kid's imagination, throw them into a room full of science experiments and let 'em have at it. That's exactly what happened at the recent Society of Women Engineers' Innovation Expo in Boston's Seaport District. The place was buzzing, and not just because of all the engineering gadgets on display—it was the energy of young minds...

Continue Reading
Future FinTech Under Investigation: Shareholder Impact Looms

Updated Category News Views 81

Future FinTech Faces Legal Scrutiny When the walls close in under financial suspicion, the spotlight can burn brighter than any anticipated market gain. That's precisely what Future FinTech Group Inc. (NasdaqCM: FTFT) is up against now. Kahn Swick & Foti, LLC, featuring the ex-Attorney General of Louisiana, Charles C. Foti, Jr., has begun scrutinizing the actions of...

Continue Reading

Top 5 Most Recently Viewed Articles

TotalEnergies Repurchases Shares Valued at €56 Million

Updated Category News Views 99

TotalEnergies Repurchases Significant Shares TotalEnergies (NYSE: TTE) has made headlines with its latest move to buy back its own shares, valuing approximately €56 million. This major transaction spanned four days, during which the energy firm acquired 1,082,058 shares for a total sum of €55,999,836.72. With operations in around 120 countries, TotalEnergies continues...

Continue Reading
Musical Journey Celebrates U.S. in New Armstrong Collection

Updated Category News Views 12

A Musical Ode for America's 250th David Armstrong has decided to hit the road musically, and he's taking listeners along for a ride like no other. Celebrating the U.S. of A.'s 250th anniversary, Armstrong's three-volume collection, "My Country 'Tis of Thee," offers a deep dive into each of the 50 states with original tunes that showcase their essence. And at this...

Continue Reading
Legal Action Initiated to Protect Investors of Metagenomi, Inc.

Updated Category News Views 119

Metagenomi, Inc. Faces Class Action Lawsuit The Gross Law Firm has announced a class action lawsuit on behalf of shareholders of Metagenomi, Inc. (NASDAQ: MGX). This legal action is designed to seek recovery for investors who purchased shares during the designated class period. Shareholders are urged to reach out to the firm to learn about possible lead plaintiff...

Continue Reading
Infisical Raises $16M to Transform Secrets Management Landscape

Updated Category News Views 349

Infisical Secures $16 Million Series A Funding Infisical, a trailblazer in open-source solutions for secrets, identity, and access management, recently announced a significant funding milestone. The company has closed a remarkable $16 million in Series A funding led by esteemed investor Elad Gil. This funding is poised to bring transformative advantages to startups, large...

Continue Reading
Amylyx Pharmaceuticals: Strong Trial Results Bolster Stock

Updated Category News Views 78

Amylyx Pharmaceuticals Maintains Momentum with Positive Trial Outcomes Amylyx Pharmaceuticals Inc. (NASDAQ: AMLX) is currently in the spotlight as it maintains a favorable position in the market following significant trial results. The company has received a Buy rating from H.C. Wainwright, underpinned by a steadfast price target of $8.00. This positive outlook is largely...

Continue Reading